|
![]() |
|
|
Oxytetracycline: profile and news
Club Feet Apr 24, 2006 Other information Indication Oxytetracycline is indicated for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae. Pharmacology Oxytetracycline, a macrolide antibiotic similar to erythromycin and azithromycin, is effective against Mycobacterium avium complex (MAC) and is used for the treatment of Helicobacter pylori-associated peptic ulcer disease, community-acquired pneumonia, sinusitis, and chronic bronchitis. Oxytetracycline is also used to treat respiratory tract, sexually transmitted, otitis media, and AIDS-related infections. Mechanism Of Action Oxytetracycline inhibits cell growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. The binding is reversible in nature. Oxytetracycline is lipophilic and can easily pass through the cell membrane or passively diffuses through porin channels in the bacterial membrane. Drug Category Anti-bacterial Agents; Tetracyclines; ATC:D06AA03; ATC:G01AA07; ATC:J01AA06; ATC:S01AA04 Brand Names/Synonyms Oxytetracycline; Oxytetracycline Anhydrous; Oxytetracycline Hcl; Terramycin Dosage Forms DRUG PREMIX Absorption Not Available Interactions Interactions for Oxytetracycline: No Information Provided Chemical IUPAC Name 2-(amino-hydroxy-methylidene)-4-dimethylamino-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a,6,12a-hexahydrotetracene-1,3,12-trione Chemical Formula C22H24N2O9 Half Life Not Available Drug Type Approved Drug # Accession No APRD00019 CAS Registry Number 79-57-2 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |